                               SEQUENCE LISTING

<110> REGENERON PHARMACEUTICALS, INC.
 
<120> IDENTIFICATION AND PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODIES

<130> 2010794-2338

<140> PCT/US21/49887
<141> 2021-09-10

<150> 63/077,140
<151> 2020-09-11

<150> 63/077,133
<151> 2020-09-11

<160> 40    

<170> PatentIn version 3.5

<210> 1
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<220>
<223> Template Switching Primer

<400> 1
caccatcgat gtcgacacgc ctaggg                                            26


<210> 2
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 1st Round PCR Primer - IgG Constant

<400> 2
ggaaggtgtg cacaccgctg gac                                               23


<210> 3
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 1st Round PCR Primer - IgG Constant

<400> 3
ggaaggtgtg cacactgctg gac                                               23


<210> 4
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 1st Round PCR Primer - IgG Constant

<400> 4
ggaaggtgtg cacaccactg gac                                               23


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 1st Round PCR Primer - IgG Constant

<400> 5
agactgtgcg cacaccgctg gac                                               23


<210> 6
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 1st Round PCR Primer - TS Specific

<400> 6
aagcagtggt atcaacgcag agtacat                                           27


<210> 7
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 2nd Round PCR Primer - IgG Constant

<400> 7
acactctttc cctacacgac gctcttccga tctagtggat agacagatgg gggtg            55


<210> 8
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 2nd Round PCR Primer - IgG Constant

<400> 8
acactctttc cctacacgac gctcttccga tctagtggat agactgatgg gggtg            55


<210> 9
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 2nd Round PCR Primer - IgG Constant

<400> 9
acactctttc cctacacgac gctcttccga tctagtggat agaccgatgg ggctg            55


<210> 10
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 2nd Round PCR Primer - IgG Constant

<400> 10
acactctttc cctacacgac gctcttccga tctaagggat agacagatgg ggctg            55


<210> 11
<211> 57
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> 2nd Round PCR Primer - TS Specific

<400> 11
gtgactggag ttcagacgtg tgctcttccg atctcaccat cgatgtcgac acgccta          57


<210> 12
<211> 68
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<220>
<223> Final Round PCR Primer - Forward


<220>
<221> modified_base
<222> (30)..(35)
<223> a, c, t, g, unknown or other

<220>
<221> misc_feature
<222> (30)..(35)
<223> Six base pair index sequence to enable multiplexing samples for 
      sequencing

<400> 12
aatgatacgg cgaccaccga gatctacacn nnnnnacact ctttccctac acgacgctct       60

tccgatct                                                                68


<210> 13
<211> 64
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      Primer

<220>
<223> Final Round PCR Primers - Reverse


<220>
<221> modified_base
<222> (25)..(30)
<223> a, c, t, g, unknown or other

<220>
<221> misc_feature
<222> (25)..(30)
<223> Six base pair index sequence to enable multiplexing samples for 
      sequencing

<400> 13
caagcagaag acggcatacg agatnnnnnn gtgactggag ttcagacgtg tgctcttccg       60

atct                                                                    64


<210> 14
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 14
Gln Met Leu Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ala Phe 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Thr Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asn Trp Ile Pro Trp Phe Asp Pro Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser Ala Lys 
        115                 120 


<210> 15
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ala Ser Gly Tyr Thr Phe Thr Ala Phe Tyr Ile His Trp Val Arg 
1               5                   10                  15  


<210> 16
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
1               5                   10      


<210> 17
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Asp Asn Trp Ile Pro Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val 
1               5                   10                  15      


Thr Val Ser Ser Ala Lys 
            20          


<210> 18
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Arg Asp Asn Trp Ile Pro Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu 
1               5                   10                  15      


Val Thr Val Ser Ser Ala Lys 
            20              


<210> 19
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Glu Asn Val Thr Ile Ile Arg Gly Ile Asn Gly Trp Phe Asp Ser 
1               5                   10                  15  


<210> 20
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Gln Asp Ile Ala Leu Val Arg Gly Val Ile Asn Ile Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210> 21
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ala Gly Ile Leu Gly Ala Pro Asn Trp Phe Asp Pro 
1               5                   10          


<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Ala Gly Gly Leu Arg Val Trp Phe Asp Pro 
1               5                   10  


<210> 23
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Glu Gly Leu Val Ile Pro Leu Leu Asp Tyr 
1               5                   10  


<210> 24
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
His Ile Asp Pro Gly Leu Ile Val Thr Arg Ala Leu Asp Tyr 
1               5                   10                  


<210> 25
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
His Gly Gly Leu Arg Leu Gly Tyr Leu Ser Leu Tyr Arg Asp Tyr 
1               5                   10                  15  


<210> 26
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Gly Pro Gly Leu Tyr Tyr Gly Met Asp Val 
1               5                   10  


<210> 27
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Ile Ser Arg Val Ser Ala Ala Gly Gly Asp Tyr 
1               5                   10      


<210> 28
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
His Ser Arg Leu Thr Ala Ala Gly Pro Asp Tyr 
1               5                   10      


<210> 29
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Gln Ala Arg Thr Ala Ala Ala Gly Pro Asp Tyr 
1               5                   10      


<210> 30
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
His Ala Arg Ser Ile Ala Ala Arg Gly Asp Tyr 
1               5                   10      


<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Lys Asp Arg Ile Ile Gly Thr Asp Tyr 
1               5                   


<210> 32
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Ala Arg Asp Pro Leu Ser Ser Ser Leu Asp Tyr 
1               5                   10      


<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Gly Phe Arg Tyr Pro Leu Glu Tyr 
1               5               


<210> 34
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Asp Asn Phe His Phe Asp Tyr 
1               5           


<210> 35
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Asp Arg Ala Thr Gly Thr Tyr Trp Asp Tyr Phe Asp Tyr 
1               5                   10              


<210> 36
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Trp Asp Tyr His Phe Asp Tyr 
1               5               


<210> 37
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Asp Tyr Tyr Ala Ser Gly Ser Tyr Tyr Lys Gly Asn Trp Phe Asp Ser 
1               5                   10                  15      


<210> 38
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Asp Asn Trp Ile Pro Trp Phe Asp Pro 
1               5                   


<210> 39
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Gly Leu Ser Gly Ser Gln Gly Tyr 
1               5               


<210> 40
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Asp Asp Leu Arg Tyr Phe Asp Trp Leu Leu Gly Tyr 
1               5                   10          


